A randomized controlled trial of antibiotics targeting adherent and invasive <i>Escherichia coli</i> versus placebo in Crohn’s disease: the TEOREM trial

A combination of ciprofloxacin and rifaximin was not superior to placebo to achieve endoscopic endpoints in patients with ileal CD colonized with AIEC.

Authors

Institutions

Publication Details

Journal
Journal of Crohn s and Colitis
Published
2025-06-13
DOI
https://doi.org/10.1093/ecco-jcc/jjaf093
Citations
2
Primary Topic
Inflammatory Bowel Disease
Type
article
Field-Weighted Citation Impact
3.63
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

A randomized controlled trial of antibiotics targeting adherent and invasive Escherichia coli versus placebo in Crohn’s disease: the TEOREM trial

Fréderic Faure, Pauline Wils, C. Le Breton, David Laharie et al.
2 citations
Journal of Crohn s and Colitis
Inflammatory Bowel Disease
3.63
article

A randomized controlled trial of antibiotics targeting adherent and invasive Escherichia coli versus placebo in Crohn’s disease: the TEOREM trial

Fréderic Faure, Pauline Wils, C. Le Breton, David Laharie, Christophe Michiels, Jean‐Frédéric Colombel, Patricia Lepage, Franck Carbonnel, Antoine Meyer, Nicolas Barnich, Matthieu Allez, R. Balfour Sartor, Anouk Walter‐Petrich, Anthony Buisson, Yoram Bouhnik, Domitille Molinari, Caroline Chevarin, Cyrielle Gilletta, Romain Altwegg, Sylvie Chevret, Xavier Hébuterne, Hélène Agostini, Jean Yves Mary
article en
2 citations

Abstract

A combination of ciprofloxacin and rifaximin was not superior to placebo to achieve endoscopic endpoints in patients with ileal CD colonized with AIEC.

Journal of Crohn s and ColitisVol. 19(7)
University of North Carolina at Chapel Hill (US), Université de Bordeaux (FR), Inserm (FR), Université de Bourgogne (FR), Université Fédérale de Toulouse Midi-Pyrénées (FR), Université Paris Cité (FR), Université de Lille (FR), Université Paris-Saclay (FR), Hôpital Beaujon (FR), Microbiologie de l’alimentation au service de la santé (FR), Centre Hospitalier Universitaire de Bordeaux (FR), Centre Hospitalier Universitaire de Nice (FR), Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement (FR), Lille’s Cardiology Hospital (FR), Sorbonne Paris Cité (FR), Centre Hospitalier Universitaire de Montpellier (FR), Laboratoire d'études sur les monothéismes (FR), Hôpital Cardiologique du Haut-Lévêque (FR), Microbe, Intestine, Inflammation and Host Susceptibility (FR), Centre Hospitalier Universitaire de Clermont-Ferrand (FR), Maison des Sciences sociales et des Humanités de Dijon (FR), Clermont Université (FR), Hôpital Saint-Louis (FR), Bicêtre Hospital (FR), Icahn School of Medicine at Mount Sinai (US)
Openalex Percentile: Top 8%
Inflammatory Bowel Disease
3.63
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.